(Q82241176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Clinical management of BRCA1 and BRCA2 mutation carriers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

Susan M Domchek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Katrina Armstrong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Barbara L Weber

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Oncology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0384

7 January 2021

Identifiers

DOI

10.1038/NCPONC0384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference